您当前所在的位置:首页 > 产品中心 > 产品详细信息
3736-81-0 分子结构
点击图片或这里关闭

4-(2,2-dichloro-N-methylacetamido)phenyl furan-2-carboxylate

ChemBase编号:6394
分子式:C14H11Cl2NO4
平均质量:328.14744
单一同位素质量:327.0065132
SMILES和InChIs

SMILES:
ClC(Cl)C(=O)N(c1ccc(OC(=O)c2occc2)cc1)C
Canonical SMILES:
O=C(N(c1ccc(cc1)OC(=O)c1ccco1)C)C(Cl)Cl
InChI:
InChI=1S/C14H11Cl2NO4/c1-17(13(18)12(15)16)9-4-6-10(7-5-9)21-14(19)11-3-2-8-20-11/h2-8,12H,1H3
InChIKey:
BDYYDXJSHYEDGB-UHFFFAOYSA-N

引用这个纪录

CBID:6394 http://www.chembase.cn/molecule-6394.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
4-(2,2-dichloro-N-methylacetamido)phenyl furan-2-carboxylate
IUPAC传统名
diloxanide furoate
diloxanide
别名
Diloxanide furoate
Diloxanide
2,2-Dichloro-N-(4-hydroxyphenyl)-N-methylacetamide 2-furoic acid ester
Diloxanide furoate
CAS号
3736-81-0
EC号
223-108-1
MDL号
MFCD00083302
PubChem SID
160969701
24894026
PubChem CID
19529

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID 价格
Sigma Aldrich
D6413 external link 加入购物车 请登录

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 13.090932  质子受体
质子供体 LogD (pH = 5.5) 3.0782325 
LogD (pH = 7.4) 3.0782318  Log P 3.0782325 
摩尔折射率 78.2065 cm3 极化性 29.89647 Å3
极化表面积 59.75 Å2 可自由旋转的化学键
里宾斯基五规则 true 
Log P 3.33  LOG S -3.93 
溶解度 3.82e-02 g/l 

分子性质

分子性质

安全信息 生物活性(PubChem)
RTECS编号
LV1821800 expand 查看数据来源
欧盟危险性物质标志
有害性(Harmful) 有害性(Harmful) (Xn) expand 查看数据来源
德国WGK号
3 expand 查看数据来源
危险公开号
22 expand 查看数据来源
安全公开号
36 expand 查看数据来源
GHS危险品标识
GHS07 expand 查看数据来源
GHS警示词
Warning expand 查看数据来源
GHS危险声明
H302 expand 查看数据来源
个人保护装置
dust mask type N95 (US), Eyeshields, Gloves expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank
DrugBank -  DB08792 external link
Item Information
Drug Groups approved
Description Diloxanide furoate is an anti-protozoal drug used in the treatment of Entamoeba histolytica and some other protozoal infections. Although it is not currently approved for use in the United States, it was approved by a CDC study in the treatment of 4,371 cases of Entamoeba histolytica from 1977 to 1990.
Indication Diloxanide is used alone as a primary agent in the treatment of asymptomatic (cyst passers) intestinal amebiasis caused by Entamoeba histolytica. Diloxanide may also be used concurrently, or sequentially, with other agents such as the nitroimidazoles (eg. metronidazole) in the treatment of invasive or extraintestinal forms of amebiasis.
Pharmacology Diloxanide is a luminal amebicide, however the mechanism of action of diloxanide is unknown. Diloxanide destroys the trophozoites of E. histolytica that eventually form into cysts. The cysts are then excreted by persons infected with asymptomatic amebiasis. Diloxanide furoate is a prodrug, and is hydrolyzed in the gastrointestinal tract to produce diloxanide, the active ingredient.
Affected Organisms
Protozoa
Biotransformation Hydrolyzed to furoic acid and diloxanide, which undergoes extensive glucuronidation (99% of diloxanide occurs as glucuronide and 1% as free diloxanide in the systemic circulation).
Absorption Bioavailability is 90% (in diloxanide parental form), however diloxanide furoate is slowly absorbed from the gastrointestinal tract.
Half Life 3 hours
Elimination Renal (90%, rapidly excreted as glucuronide metabolite). 10% is excreted in the feces as diloxanide.
References
McAuley JB, Herwaldt BL, Stokes SL, Becher JA, Roberts JM, Michelson MK, Juranek DD: Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States. Clin Infect Dis. 1992 Sep;15(3):464-8. [Pubmed]
External Links
Wikipedia
Drugs.com

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • McAuley JB, Herwaldt BL, Stokes SL, Becher JA, Roberts JM, Michelson MK, Juranek DD: Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States. Clin Infect Dis. 1992 Sep;15(3):464-8. Pubmed
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle